-
¹ØÓÚÁú8Ψһ¹ÙÍø
-
-
ÐÂÎŶ¯Ì¬
-
-
-
Éç»áÔðÈÎ
-
Ͷ×ÊÕß¹Øϵ
²úÆ·ÖÐÐÄ
ÁªÏµÁú8Ψһ¹ÙÍø
ÏúÊÛרÓãº
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
Y-shape PEG Amine
²úÆ·´úºÅ£º
Y-PEG-NH2
²úÆ·´¿¶È£º
¡Ý 95%
°ü×°¹æ¸ñ£º
1g, 10g, 100gµÈ£¨ÌØÊâ°ü×°ÐèÊÕÈ¡·Ö×°Óöȣ©
·Ö×ÓÁ¿£º
40000 DaµÈ
Òªº¦´Ê£º
ËùÊô·ÖÀࣺ
¿ÆÑпͻ§Ð¡ÅúÁ¿Ò»¼ü²É¹ºµØµã£¨Ð¡ÓÚ5¿Ë£©
- ²úÆ·ÃèÊö
- ²Î¿¼ÎÄÏ×
-
¡¡¡¡¾ßÓÐYÐÍ·ÖÖ§µÄY-¾ÛÒÒ¶þ´¼°±»ù»¯ºÏÎï¿ÉÒÔÓëµ×ÎïÐγÉõ£°·¡¢ëåÍé»ò¶þ¼¶°·µÈ¾ßÓÐÎȶ¨½á¹¹µÄ»¯Ñ§¼ü¡£YÐÍ°·¾ÛÒÒ¶þ´¼½á¹¹Öеݱ»ù»¯ôÇ»ù¸üÒ×ÓÚÓë±ûÏ©õ£»¯ÊÔ¼Á½øÐз´Ó¦£¬Ëü»¹ÈÝÒ×±¬·¢»¹Ô°±»ù»¯·´Ó¦¡£Áú8Ψһ¹ÙÍø²úÆ·Y·ÖÖ§ÑÜÉúÎïÊÇ×ÔÖ÷Ñз¢µÄYÐͽṹ£¬ÓÉÓÚ¾ßÓÐÆæÌصĿռä½á¹¹Ê¹ËûÃDZÈÏßÐÔ¾ÛÒÒ¶þ´¼ÑÜÉúÎï¸ü¾ßÓÐÑ¡ÔñÐÔ¡£
²úÆ·±àÂë
²úÆ·´úºÅ
A0010F
Y-NH2-40K
A0044
Y-NH2HCl-40K
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Ìṩ·ÖװЧÀÍ£¬ÐèÒªÊÕÈ¡·Ö×°Óöȣ¬Èç¹ûÄúÐèÒª·ÖװΪÆäËû¹æ¸ñÇëÓëÎÒÃÇÁªÏµ¡£
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Í¬Ê±ÌṩÆäËû·Ö×ÓÁ¿µÄYÐÍÑÜÉúÎï²úÆ·£¬ÈçÄãÐèÒªÇëÓëÎÒ˾sales@jenkem.comÁªÏµ¡£
¡¡¡¡Áú8Ψһ¹ÙÍø¿Æ¼¼Ìṩ´óÅúÁ¿Éú²ú²úÆ·¼°GMP¼¶±ð²úÆ·£¬ÈçÐ豨¼ÛÇëÓëÎÒÃÇÁªÏµ¡£
-
¡¡¡¡References:
¡¡¡¡1. Amoozgar, Z., et al., Dual-layer surface coating of PLGA-based nanoparticles provides slow-release drug delivery to achieve metronomic therapy in a paclitaxel-resistant murine ovarian cancer model, Biomacromolecules. 2014, 15(11):4187-94.
¡¡¡¡2. Hoehlig, K., et al., A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis. Mol Ther, 2013, 21(12): p. 2236-46.
²úƷѯ¼Û
Áú8Ψһ¹ÙÍø
ЧÀÍÈÈÏߣº+86-010-82156767
ÏúÊÛרÓãº+86-010-62983737
²úÆ·×Éѯ£ºsales@jenkem.com
µØµã£º±±¾©Êк£µíÇøÎ÷С¿Ú·66ºÅÖйش嶫Éý¿Æ¼¼Ô°C-1Â¥Èý²ã
΢ÐÅÃñÖÚºÅ
΢ÐÅÃñÖÚºÅ